Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Natalia M. Felitsyn"'
Publikováno v:
Journal of Neurochemistry. 100:429-436
Dichloroacetate (DCA) is an investigational drug for genetic mitochondrial diseases whose use has been mitigated by reversible peripheral neuropathy. We investigated the mechanism of DCA neurotoxicity using cultured rat Schwann cells (SCs) and dorsal
Controlled Clinical Trial of Dichloroacetate for Treatment of Congenital Lactic Acidosis in Children
Autor:
Janet H. Silverstein, Richard E. Neiberger, Douglas W. Theriaque, Alan D. Hutson, Robin L. Gilmore, Jonathan J. Shuster, Douglas S. Kerr, Paul R. Carney, Eileen M. Fennell, Albert L. Shroads, Leigh Ann Perkins, George N. Henderson, Ronald G. Quisling, Natalia M. Felitsyn, S. Terri Bunch, Melvin Greer, Carie L. Barnes, Ralph G. O'Brien, Edward Valenstein, Peter W. Stacpoole
Publikováno v:
Pediatrics. 117:1519-1531
OBJECTIVE. Open-label studies indicate that oral dichloroacetate (DCA) may be effective in treating patients with congenital lactic acidosis. We tested this hypothesis by conducting the first double-blind, randomized, control trial of DCA in this dis
Publikováno v:
Clinica Chimica Acta. 350:219-230
Several acquired and congenital human disorders perturb the concentrations of delta-aminolevulinate (delta-ALA), creatinine and tyrosine in biological fluids. There is currently no facile, sensitive and specific method to measure these analytes simul
Publikováno v:
Journal of Neurochemistry.
Delta-aminolevulinic acid (delta-ALA) is a heme precursor implicated in neurological complications associated with porphyria and tyrosinemia type I. Delta-ALA is also elevated in the urine of animals and patients treated with the investigational drug
Autor:
Nigel A. Calcutt, Peter W. Stacpoole, Lucia Notterpek, Natalia M. Felitsyn, Albert L. Shroads
Publikováno v:
Mitochondrion. 6:17-18